Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Dittrich

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
European Journal of Cancer (Oxford, England : 1990)|June 1, 2012
Tumor characteristics and recurrence patterns in triple negative breast cancer: a comparison between younger (<65) and elderly (≥65) patientsRobert Königsberg, Georg Pfeiler, Tatjana Klement, et al.
Cancer Chemotherapy and Pharmacology|February 18, 2018
Monitoring of erlotinib in pancreatic cancer patients during long-time administration and comparison to a physiologically based pharmacokinetic modelAndrea Gruber, Martin Czejka, Philipp Buchner, et al.
Investigational New Drugs|December 23, 2014
A phase 1 dose escalation study of BI 831266, an inhibitor of Aurora kinase B, in patients with advanced solid tumorsChristian Dittrich, Michael A Fridrik, Robert Koenigsberg, et al.
Radiology and Oncology|August 31, 2012
Frequent MGMT (0(6)-methylguanine-DNA methyltransferase) hypermethylation in long-term survivors of glioblastoma: a single institution experienceMartina Baur, Matthias Preusser, Maria Piribauer, et al.
Cancer Investigation|July 31, 2008
Cell cycle dysregulation influences survival in high risk breast cancer patientsRobert Königsberg, Olga Rögelsperger, Walter Jäger, et al.
Cancer Letters|February 20, 2010
Circulating tumor cells in metastatic colorectal cancer: efficacy and feasibility of different enrichment methodsRobert Königsberg, Margit Gneist, Daniela Jahn-Kuch, et al.
Oncology|January 18, 2012
Clinical and economic aspects of KRAS mutational status as predictor for epidermal growth factor receptor inhibitor therapy in metastatic colorectal cancer patientsRobert Königsberg, Wolfgang Hulla, Martin Klimpfinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Phase I and pharmacokinetic study of E7070, a chloroindolyl-sulfonamide anticancer agent, administered on a weekly schedule to patients with solid tumorsChristian Dittrich, Herlinde Dumez, Hilary Calvert, et al.
British Journal of Clinical Pharmacology|July 22, 2008
Population pharmacokinetic and pharmacodynamic analysis to support treatment optimization of combination chemotherapy with indisulam and carboplatinAnthe S Zandvliet, Jan H M Schellens, Christian Dittrich, et al.
Investigational New Drugs|July 13, 2018
Phase Ib trial combining capecitabine, erlotinib and bevacizumab in pancreatic adenocarcinoma - REBECA trialChristian Dittrich, Robert Königsberg, Martina Mittlböck, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
European Journal of Cancer (Oxford, England : 1990)|June 1, 2012
Tumor characteristics and recurrence patterns in triple negative breast cancer: a comparison between younger (<65) and elderly (≥65) patientsRobert Königsberg, Georg Pfeiler, Tatjana Klement, et al.
Cancer Chemotherapy and Pharmacology|February 18, 2018
Monitoring of erlotinib in pancreatic cancer patients during long-time administration and comparison to a physiologically based pharmacokinetic modelAndrea Gruber, Martin Czejka, Philipp Buchner, et al.
Investigational New Drugs|December 23, 2014
A phase 1 dose escalation study of BI 831266, an inhibitor of Aurora kinase B, in patients with advanced solid tumorsChristian Dittrich, Michael A Fridrik, Robert Koenigsberg, et al.
Radiology and Oncology|August 31, 2012
Frequent MGMT (0(6)-methylguanine-DNA methyltransferase) hypermethylation in long-term survivors of glioblastoma: a single institution experienceMartina Baur, Matthias Preusser, Maria Piribauer, et al.
Cancer Investigation|July 31, 2008
Cell cycle dysregulation influences survival in high risk breast cancer patientsRobert Königsberg, Olga Rögelsperger, Walter Jäger, et al.
Cancer Letters|February 20, 2010
Circulating tumor cells in metastatic colorectal cancer: efficacy and feasibility of different enrichment methodsRobert Königsberg, Margit Gneist, Daniela Jahn-Kuch, et al.
Oncology|January 18, 2012
Clinical and economic aspects of KRAS mutational status as predictor for epidermal growth factor receptor inhibitor therapy in metastatic colorectal cancer patientsRobert Königsberg, Wolfgang Hulla, Martin Klimpfinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Phase I and pharmacokinetic study of E7070, a chloroindolyl-sulfonamide anticancer agent, administered on a weekly schedule to patients with solid tumorsChristian Dittrich, Herlinde Dumez, Hilary Calvert, et al.
British Journal of Clinical Pharmacology|July 22, 2008
Population pharmacokinetic and pharmacodynamic analysis to support treatment optimization of combination chemotherapy with indisulam and carboplatinAnthe S Zandvliet, Jan H M Schellens, Christian Dittrich, et al.
Investigational New Drugs|July 13, 2018
Phase Ib trial combining capecitabine, erlotinib and bevacizumab in pancreatic adenocarcinoma - REBECA trialChristian Dittrich, Robert Königsberg, Martina Mittlböck, et al.
Pageof 8